Li H, Liu C, Li R, Zhou L, Ran Y, Yang Q, Huang H, Lu H, Song H, Yang B, Ru H, Lin S, Zhang L*. AARS1 and AARS2 Sense L-lactate to regulate cGAS as global lysine lactyltransferase. Nature. (IF=50.5) (2024 Oct;634(8036):1229-1237)
Li H, Zhou F*, Zhang L*. STING, a critical contributor to SARS-CoV-2 immunopathology. Signal Transduct Target Ther. (IF=39.3) (2022 Mar 30;7(1):106)
Li H, Zhou F*, Zhang L*. ADP-riboxanation: a new pyroptosis evasion strategy. J Mol Cell Biol. (IF=8.2) (2022 Mar 21;14(1):mjab077)
Xie F#, Zhou X#, Li H, Su P, Liu S, Li R, Zou J, Wei X, Pan C, Zhang Z, Zheng M, Liu Z, Meng X, Ovaa H, Ten Dijke P*, Zhou F*, Zhang L*. USP8 promotes cancer progression and extracellular vesicle-mediated CD8+ T cell exhaustion by deubiquitinating the TGF-β receptor TβRII. EMBO J. (IF=9.4) (2022 Aug 16;41(16):e108791)
Xie F#, Zhou X#, Su P, Li H, Tu Y, Du J, Pan C, Wei X, Zheng M, Jin K, Miao L, Wang C, Meng X, van Dam H, Ten Dijke P, Zhang L*, Zhou F*. Breast cancer cell-derived extracellular vesicles promote CD8+ T cell exhaustion via TGF-β type II receptor signaling. Nat Commun. (IF=14.7) (2022 Aug 1;13(1):4461)
Xie F#, Su P#, Pan T#, Zhou X, Li H, Huang H, Wang A, Wang F, Huang J, Yan H, Zeng L, Zhang L*, Zhou F*. Engineering Extracellular Vesicles Enriched with Palmitoylated ACE2 as COVID-19 Therapy. Adv Mater. (IF=29.4) (2021 Dec;33(49):e2103471)
Yang Q, Wang B, Zheng Q, Li H, Meng X*, Zhou F*, Zhang L*. A Review of Gut Microbiota-Derived Metabolites in Tumor Progression and Cancer Therapy. Adv Sci (Weinh). (IF=15.1) (2023 May;10(15):e2207366)
Xie F, Zhou X, Fang M, Li H, Su P, Tu Y, Zhang L, Zhou F*. Extracellular Vesicles in Cancer Immune Microenvironment and Cancer Immunotherapy. Adv Sci (Weinh). (IF=15.1) (2019 Oct 23;6(24):1901779)
代谢与蛋白质动态调控
Li H, Liu C, Li R, Zhou L, Ran Y, Yang Q, Huang H, Lu H, Song H, Yang B, Ru H, Lin S, Zhang L*. AARS1 and AARS2 Sense L-lactate to regulate cGAS as global lysine lactyltransferase. Nature. (IF=50.5) (2024 Oct;634(8036):1229-1237)
Li H, Zhou F*, Zhang L*. STING, a critical contributor to SARS-CoV-2 immunopathology. Signal Transduct Target Ther. (IF=39.3) (2022 Mar 30;7(1):106)
Li H, Zhou F*, Zhang L*. ADP-riboxanation: a new pyroptosis evasion strategy. J Mol Cell Biol. (IF=8.2) (2022 Mar 21;14(1):mjab077)
Xie F#, Zhou X#, Li H, Su P, Liu S, Li R, Zou J, Wei X, Pan C, Zhang Z, Zheng M, Liu Z, Meng X, Ovaa H, Ten Dijke P*, Zhou F*, Zhang L*. USP8 promotes cancer progression and extracellular vesicle-mediated CD8+ T cell exhaustion by deubiquitinating the TGF-β receptor TβRII. EMBO J. (IF=9.4) (2022 Aug 16;41(16):e108791)
Xie F#, Zhou X#, Su P, Li H, Tu Y, Du J, Pan C, Wei X, Zheng M, Jin K, Miao L, Wang C, Meng X, van Dam H, Ten Dijke P, Zhang L*, Zhou F*. Breast cancer cell-derived extracellular vesicles promote CD8+ T cell exhaustion via TGF-β type II receptor signaling. Nat Commun. (IF=14.7) (2022 Aug 1;13(1):4461)
Xie F#, Su P#, Pan T#, Zhou X, Li H, Huang H, Wang A, Wang F, Huang J, Yan H, Zeng L, Zhang L*, Zhou F*. Engineering Extracellular Vesicles Enriched with Palmitoylated ACE2 as COVID-19 Therapy. Adv Mater. (IF=29.4) (2021 Dec;33(49):e2103471)
Yang Q, Wang B, Zheng Q, Li H, Meng X*, Zhou F*, Zhang L*. A Review of Gut Microbiota-Derived Metabolites in Tumor Progression and Cancer Therapy. Adv Sci (Weinh). (IF=15.1) (2023 May;10(15):e2207366)
Xie F, Zhou X, Fang M, Li H, Su P, Tu Y, Zhang L, Zhou F*. Extracellular Vesicles in Cancer Immune Microenvironment and Cancer Immunotherapy. Adv Sci (Weinh). (IF=15.1) (2019 Oct 23;6(24):1901779)
